Chohee Yun

1.6k total citations
27 papers, 760 citations indexed

About

Chohee Yun is a scholar working on Genetics, Genetics and Molecular Biology. According to data from OpenAlex, Chohee Yun has authored 27 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Chohee Yun's work include Inflammatory Bowel Disease (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Hepatitis C virus research (5 papers). Chohee Yun is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Hepatitis C virus research (5 papers). Chohee Yun collaborates with scholars based in United States, South Korea and Germany. Chohee Yun's co-authors include Wook Jin, Diana M. Brainard, Hadas Dvory‐Sobol, John G. McHutchison, Robert H. Hyland, Seong‐Jin Kim, Gregory J. Dore, Seong‐Jin Kim, Joon Jeong and Stanislas Pol and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Annals of Internal Medicine.

In The Last Decade

Chohee Yun

26 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chohee Yun United States 13 395 369 180 128 91 27 760
Vincent Leroy France 17 636 1.6× 545 1.5× 58 0.3× 87 0.7× 112 1.2× 41 945
Zhenwen Liu China 10 212 0.5× 125 0.3× 104 0.6× 58 0.5× 51 0.6× 28 570
Giovanni Covini Italy 11 439 1.1× 434 1.2× 289 1.6× 55 0.4× 95 1.0× 17 925
Katrien Vekemans Belgium 17 442 1.1× 173 0.5× 217 1.2× 20 0.2× 104 1.1× 49 899
Roberto Aiolfi United States 7 264 0.7× 281 0.8× 80 0.4× 45 0.4× 156 1.7× 16 698
Filoména Conti France 17 481 1.2× 331 0.9× 153 0.8× 12 0.1× 70 0.8× 35 868
Weiqiang Ju China 17 400 1.0× 261 0.7× 249 1.4× 23 0.2× 113 1.2× 74 948
Yih-Jyh Lin Taiwan 14 162 0.4× 122 0.3× 149 0.8× 18 0.1× 110 1.2× 23 501
Chan Xie China 17 427 1.1× 336 0.9× 415 2.3× 65 0.5× 107 1.2× 43 1.1k
Hui-Hua Hsiao Taiwan 10 216 0.5× 256 0.7× 83 0.5× 16 0.1× 136 1.5× 17 555

Countries citing papers authored by Chohee Yun

Since Specialization
Citations

This map shows the geographic impact of Chohee Yun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chohee Yun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chohee Yun more than expected).

Fields of papers citing papers by Chohee Yun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chohee Yun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chohee Yun. The network helps show where Chohee Yun may publish in the future.

Co-authorship network of co-authors of Chohee Yun

This figure shows the co-authorship network connecting the top 25 collaborators of Chohee Yun. A scholar is included among the top collaborators of Chohee Yun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chohee Yun. Chohee Yun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Huiqin, et al.. (2025). Application of EGFR-TKIs in brain tumors, a breakthrough in future?. Journal of Translational Medicine. 23(1). 449–449. 1 indexed citations
2.
3.
4.
Hibi∥, Toshifumi, Satoshi Motoya, Tadakazu Hisamatsu, et al.. (2022). Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial. Intestinal Research. 21(1). 110–125. 13 indexed citations
5.
Danese, Silvio, Marc Ferrante, Brian G. Feagan, et al.. (2022). Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial. The American Journal of Gastroenterology. 118(1). 138–147. 18 indexed citations
6.
Danese, Silvio, Toshifumi Hibi∥, Timothy E. Ritter, et al.. (2021). OP37 Rapidity of symptom improvements during filgotinib induction therapy in patients with Ulcerative Colitis: Post hoc analysis of the phase 2b/3 SELECTION study. Journal of Crohn s and Colitis. 15(Supplement_1). S034–S035. 1 indexed citations
7.
Rubin, Samuel J. S., Lawrence Bai, Yeneneh Haileselassie, et al.. (2019). Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases. Nature Communications. 10(1). 2686–2686. 70 indexed citations
8.
Xin, Yan, Hao Zheng, Chohee Yun, et al.. (2019). Filgotinib, a JAK1 Inhibitor, Has No Effect on QT Interval in Healthy Subjects. Clinical Pharmacology in Drug Development. 9(1). 32–40. 7 indexed citations
9.
Zeuzem, Stefan, Masashi Mizokami, Stephen Pianko, et al.. (2017). NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome. Journal of Hepatology. 66(5). 910–918. 149 indexed citations
10.
Rockstroh, Jürgen K., Sanjay Bhagani, Robert H. Hyland, et al.. (2017). Ledipasvir–sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial. ˜The œLancet. Gastroenterology & hepatology. 2(5). 347–353. 50 indexed citations
11.
Grebely, Jason, Stefan Mauss, Ashley Brown, et al.. (2016). Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials. Clinical Infectious Diseases. 63(11). 1405–1411. 71 indexed citations
12.
13.
14.
Lim, Seunghwan, Eunjin Bae, Kyunghee Byun, et al.. (2012). TRAF6 Mediates IL-1β/LPS-Induced Suppression of TGF-β Signaling through Its Interaction with the Type III TGF-β Receptor. PLoS ONE. 7(3). e32705–e32705. 18 indexed citations
15.
Jin, Wook, Min Soo Kim, Chohee Yun, et al.. (2010). TrkC plays an essential role in breast tumor growth and metastasis. Carcinogenesis. 31(11). 1939–1947. 64 indexed citations
16.
Yun, Chohee, et al.. (2008). TGF‐β Signaling in Neuronal Stem Cells. Disease Markers. 24(4-5). 251–255. 12 indexed citations
17.
Jin, Wook, et al.. (2007). TrkC Binds to the Bone Morphogenetic Protein Type II Receptor to Suppress Bone Morphogenetic Protein Signaling. Cancer Research. 67(20). 9869–9877. 30 indexed citations
18.
19.
Jin, Wook, et al.. (2007). c-Src Is Required for Tropomyosin Receptor Kinase C (TrkC)-induced Activation of the Phosphatidylinositol 3-Kinase (PI3K)-AKT Pathway. Journal of Biological Chemistry. 283(3). 1391–1400. 29 indexed citations
20.
Jin, Wook, et al.. (2007). TrkC binds to the type II TGF-β receptor to suppress TGF-β signaling. Oncogene. 26(55). 7684–7691. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent Leroy Breakdown of academic impact, for papers by Zhenwen Liu Breakdown of academic impact, for papers by Giovanni Covini Breakdown of academic impact, for papers by Katrien Vekemans Breakdown of academic impact, for papers by Roberto Aiolfi Breakdown of academic impact, for papers by Filoména Conti Breakdown of academic impact, for papers by Weiqiang Ju Breakdown of academic impact, for papers by Yih-Jyh Lin Breakdown of academic impact, for papers by Chan Xie Breakdown of academic impact, for papers by Hui-Hua Hsiao
Rankless by CCL
2026